Scientists have discovered a new type of immune defense in E. coli bacteria that turns viral infection machinery against the ...

Trial Platform (PTP), led by Drs. Adam Boxer (University of California, San Francisco [UCSF]), Irene Litvan (University of California, San Diego), Julio Rojas (UCSF) and ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

Life sciences company Revvity (NYSE:RVTY) announced in Q1 CY2025, with sales up 2.3% year on year to $664.8 million. The ...

The tour concluded at Wujiang Station, an innovative cross-provincial government service center on the Jiangsu-Anhui border.

Gonadorelin, a synthetic analog of the gonadotropin-releasing hormone (GnRH), has garnered attention for its intriguing ...

In the run up to the key votes and debates on synthetic biology at the IUCN (International Union for Conservation of Nature) Congress in Abu Dhabi (9–15 October), IUCN will be hosting online ...

Microplastics, tiny plastic particles found in everyday products from face wash to toothpaste, are an emerging threat to ...

The industry’s pawprints are all over the buzzy de-extincted canine, with famous investors including Peter Jackson and George ...

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

The hurdle of being able to differentiate between cancer cells and normal cells has been a plague in the war against cancer.

Dr. Gabor Balazsi, a Henry Laufer Professor of Physical and Quantitative Biology in the Laufer Center at Stony Brook ...